Stock·NASDAQ·Industrials
Copart, Inc. (CPRT)
- Market cap
- $25.82B
- P/E
- 18.02
- Dividend yield
- 0.00%
- Street target
- $37.00median of 12 analysts
- 52-week range
- $25.72 $45.89
The short version
Where CPRT stands today, in four lines, and what CleaRank Financial AI makes of it.
CPRT at a glance
Copart, Inc. (CPRT): Hold, 45/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($30.01 and $32.89).
- Earnings CPRT beat estimates in 3 of its last 5 quarters, yet fell the next day after every one of them.
- Insiders Insiders sold $21.9M and made no open-market purchases over the last 18 months.
- Valuation P/E of 18.0 against 34.0 for the Industrials sector: a discount to peers (-47%).
Figures as of October 17, 2026.
CleaRank Financial AI
Copart, Inc. (CPRT) carries a CleaRank rating of Hold and a model score of 45/100.
The analysts' outlook does the most to lift that score: 7 of 12 analysts rate it a buy, and the median target is 32.8% above the price. The trend does the most to hold it down, with the price 15.25% below its 200-day average and 7.14% below its 50-day average, and the 50-day average 8.74% below the 200-day. The 50-day average stands at $30.01 and the 200-day at $32.89. Over the past year the price has fallen 36.75%.
Only on CleaRank
Figures we compute ourselves from CPRT's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $27.87 is 7.1% below the 50-day simple moving average of $30.01.Price above its 200-day average ›
The price is 15.3% below the 200-day simple moving average of $32.89.50-day average above the 200-day ›
The 50-day average ($30.01) is 8.7% below the 200-day average ($32.89), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 11% of its 52-week range, between $25.72 and $45.89.
CPRT share price
Pick a period: each tab shows how far CPRT has moved over it, to the last close.
Today's trading
Where CPRT sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/4P/E below the sector median ›
The trailing P/E of 18.02 is 47.0% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 5.51 is 37.7% above the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $1.5B on revenue of $4.7B, a net margin of 31.8%.Beat estimates in most recent reports ›
CPRT beat the EPS estimate in 3 of its last 5 reports.
Key statistics
The headline figures for CPRT.
As of October 17, 2026, CPRT trades at $27.87, with a market value of $25.82B and a P/E ratio of 18.02.
What the numbers say
CleaRank Financial AI's reading of CPRT's valuation, growth and risks.
Copart, Inc. (CPRT) trades at 18.02 times earnings, while the Industrials median is 34.0. That places the P/E 47.0% below the sector median, so the P/E is a discount to peers. Measured against sales, the P/S of 5.51 sits 37.8% above the sector median of 4.0. To put the size in context, CPRT has a market value of $25.8B and trailing earnings of $1.54 per share.
In the latest year revenue grew 2.40%, 9.3 percentage points slower than the sector median of 11.7%. The business earns a net margin of 31.81% and an operating margin of 32.01% and a return on equity of 16.16%, below the sector median of 17.8%. Debt-to-equity of 0.01 rounds out the fundamentals.
Copart, Inc. (CPRT) came up short in its September 10, 2026 report, with EPS of $0.35 a share against an estimate of $0.38, a miss of 7.89%. The shares dropped 2.60% in the following session.
CPRT beat the EPS estimate in 3 of its last 5 reports, yet the stock fell in the first session after every one of those 3 beats. The May 22, 2025 report stands out among the earlier ones: a miss of 0.00%, after which the stock fell 11.52%. Looking ahead, analysts expect EPS of $1.62 this fiscal year (growth of 4.6%) and $1.75 the year after (growth of 8.0%).
On a typical day the price of CPRT shifts by 2.36%, the 30-day standard deviation of its daily returns. The downtrend is itself a risk for as long as the price stays under both moving averages. The price is 39.27% below its 52-week high of $45.89. Over the last 18 months, insider sales totalled $21.9M with no open-market purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
CPRT against the Industrials sector
How CPRT compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: CPRT trades at a notable discount to sector peers (-47%), which may indicate undervaluation or specific company headwinds.
Return vs XLI: Since May 6, 2025, CPRT has lost 54.2% against a gain of 25.7% for XLI.
Performance against XLI
CPRT and the Industrials sector fund over the same days.
Revenue and earnings
How much CPRT sells, and how much of it becomes profit.
Revenue growth: Revenue grew 9.7% in FY2025 to $4.6B, from $4.2B a year earlier.
Profit margin: The net margin was 33.3% in FY2025, up from 32.2% the year before.
Profitable: CPRT earned $1.5B in FY2025.
Earnings reality check
Did CPRT beat what analysts expected, and how did the stock react?
Earnings record: CPRT beat the analyst estimate in 3 of the last 5 quarters.
Market reaction: The stock fell in the first session after 3 of those 3 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Sep 10, 2026after close | $0.38 | $0.35 | -7.89% | -2.60% | -3.54% |
| May 21, 2026after close | $0.41 | $0.43 | +4.88% | -1.77% | -4.74% |
| Sep 4, 2025after close | $0.36 | $0.41 | +13.89% | -2.80% | -2.14% |
| May 22, 2025after close | $0.42 | $0.42 | +0.00% | -11.52% | -15.13% |
| Feb 20, 2025after close | $0.37 | $0.40 | +8.11% | -2.80% | -5.14% |
As of October 17, 2026, CPRT has beaten the analyst EPS estimate in 3 of its last 5 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on September 10, 2026, came in 7.89% below the estimate and the stock moved -2.60% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 47.4, in neutral territory.RSI above 50 ›
An RSI of 47.4 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of CPRT
The score, the reasoning behind it, and what could move the price next.
Copart, Inc. (CPRT) sits under both of its moving averages, a pattern that points to a downtrend. The price of $27.87 is 7.14% below the 50-day average of $30.01 and 15.25% below the 200-day average of $32.89. Its 52-week range places the price at 11% of the way up, which leaves it 8.36% above the 52-week low of $25.72. The two averages agree on the direction: the 50-day sits 8.74% below the 200-day.
The short and long run point different ways: the price fell 9.57% over the past month, rose 0.94% over the past three months and fell 36.75% over the past year. The price rose 0.43% in the last session on volume 118.6% above its average. On momentum, the 14-day RSI reads 47.4, in the neutral zone, with the MACD line negative.
Analyst upgrade ›
Barrington Research upgraded it to Outperform from Market Perform on September 11, 2026.
Source: Analyst action, Barrington Research, September 11, 2026
Earnings miss ›
The September 10, 2026 report missed the EPS estimate by 7.89%, and the share price fell 2.60% in the first session after it.
Source: Earnings report, September 10, 2026Analyst downgrade ›
HSBC downgraded it to Hold from Buy on September 17, 2026.
Source: Analyst action, HSBC, September 17, 2026
- Keep an eye on the two closest levels: the 50-day SMA at $30.01 sits above the price, and the 20-day EMA at $27.79 sits below it.
- The 14-day RSI is 47.4, in the neutral zone, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- Following the September 10, 2026 report, the share price dropped 2.60% in the first session. CPRT has beaten estimates in 3 of the last 5 reports.
CPRT stays in a downtrend while it trades below both its 50-day average of $30.01 and its 200-day average of $32.89. A close back above the 50-day average would be the first sign of a repair. That 50-day SMA at $30.01 is the first hurdle above the price.
The first level below the price is the 20-day EMA, at $27.79. The 14-day RSI reads 47.4, which is neutral territory between 40 and 60.
Technical indicators
Momentum and trend for CPRT, from its daily closes.
As of October 17, 2026, with CPRT at $27.87, its 14-day RSI is 47.4 (neutral territory), its 50-day simple moving average is $30.01 and its 200-day is $32.89.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What CPRT moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, CPRT's 1-year correlation of daily returns is +0.28 with S&P 500 (SPY), +0.18 with Nasdaq 100 (QQQ), +0.12 with Bitcoin (BTC) and +0.07 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
7 of 12 analysts rate it a buy or strong buy, 4 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $37.00 is 32.8% above the price.More buy ratings than three months ago ›
7 of 12 rate it a buy now, against 7 of 13 three months ago.
CPRT Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 28, 2026 | BNP Paribas | Reiterates | Outperform |
| Sep 17, 2026 | HSBC | Downgrade | Hold |
| Sep 14, 2026 | Freedom Broker | Maintains | Buy |
| Sep 11, 2026 | Barrington Research | Upgrade | Outperform |
| Sep 11, 2026 | Baird | Maintains | Outperform |
| Sep 3, 2026 | JP Morgan | Upgrade | Overweight |
As of October 17, 2026, 12 Wall Street analysts cover CPRT: 7 rate it a buy or strong buy, 4 a hold and 1 a sell or strong sell. Their 12-month price targets range from $25.00 to $55.00, with a median of $37.00, 32.8% above the price of $27.87.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CPRT trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CPRT's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CPRT tends to move, against the market and on its own.
The long record
CPRT's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 2.36% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 58.9%, from May 2025 to October 2026; the price is still 56.3% below that peak.Most 1-year holds ended higher ›
75% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $41,327, against $42,055 in the S&P 500 (SPY).
CPRT Drawdowns & Recovery
As of October 17, 2026, CPRT's worst peak-to-trough fall over the last 10 years with dividends reinvested was -58.9% (May 2025 to October 2026); it is still 56.3% below that peak, and 75% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CPRT in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CPRT trailed the S&P 500 over this period: $41,327 against $42,055.
A $10,000 investment in CPRT in October 2016 would be worth about $41,327 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CPRT, and which have not.
Strongest month, November: an average of +7.78%, up in 8 of 10 years.
Weakest month, September: an average of -4.61%, up in 3 of 10 years.
This month, October: has averaged +1.91%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CPRT's strongest calendar month has been November (average +7.78%, up in 8 of 10 years) and its weakest September (average -4.61%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CPRT, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CPRT today could grow to about $24,314 by 2036 in the base case, with a 90th-percentile outcome near $76,586 and a 10th-percentile outcome around $7,719. Projections are statistical simulations, not guarantees.
CPRT Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $39.76 for CPRT by 2030 in the base case, from $27.87 today (1.4x over 4 years). The 10th-percentile path ends near $19.25. These are outcomes of a Monte Carlo simulation run on CPRT's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $21.19 | $30.46 | $43.78 | |
| 2028 | $19.93 | $33.29 | $55.61 | |
| 2029 | $19.41 | $36.38 | $68.21 | |
| 2030 | $19.25 | $39.76 | $82.15 | |
| 2031 | $19.31 | $43.46 | $97.82 |
Method: a lognormal simulation of CPRT's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
CPRT insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought CPRT shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, CPRT insiders reported 8 open-market sales worth $21.9M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 28, 2026 | Jeffrey Liaw
Chief Executive Officer
|
Sell | 27.7K | $845.9K |
| Jul 28, 2026 | Jeffrey Liaw
Chief Executive Officer
|
Option | 46.8K | $399.9K |
| Jul 15, 2026 | Jeffrey Liaw
Chief Executive Officer
|
Option | 2.1K | $15.7K |
| Jul 13, 2026 | Daniel J Englander
Director
|
Sell | 80.0K | $2.2M |
| Jul 8, 2026 | Diane M Morefield
Director
|
Option | 50.0K | $988.8K |
| Apr 15, 2026 | Jeffrey Liaw
Chief Executive Officer
|
Sell | 26.2K | $869.7K |
| Apr 15, 2026 | Jeffrey Liaw
Chief Executive Officer
|
Option | 49.8K | $422.8K |
| Jan 20, 2026 | Aaron Jayson Adair
Officer and Director
|
Grant | 50.2K | - |
| Jan 15, 2026 | Jeffrey Liaw
Chief Executive Officer
|
Sell | 25.1K | $1.0M |
| Jan 15, 2026 | Jeffrey Liaw
Chief Executive Officer
|
Option | 49.8K | $422.8K |
| Dec 30, 2025 | Thomas N Tryforos
Director
|
Grant | 27.9K | - |
| Nov 25, 2025 | Thomas N Tryforos
Director
|
Sell | 100.0K | $3.9M |
| Nov 25, 2025 | Thomas N Tryforos
Director
|
Option | 100.0K | $1.2M |
| Nov 13, 2025 | Daniel J Englander
Director
|
Option | 100.0K | $1.2M |
| Oct 15, 2025 | Jeffrey Liaw
Chief Executive Officer
|
Sell | 24.3K | $1.1M |
| Oct 15, 2025 | Jeffrey Liaw
Chief Executive Officer
|
Option | 49.8K | $422.8K |
| Sep 15, 2025 | Thomas N Tryforos
Director
|
Sell | 228.8K | $10.9M |
| Sep 15, 2025 | Thomas N Tryforos
Director
|
Option | 228.8K | $1.1M |
| Jul 15, 2025 | Jeffrey Liaw
Chief Executive Officer
|
Sell | 24.1K | $1.1M |
| Jul 15, 2025 | Jeffrey Liaw
Chief Executive Officer
|
Option | 49.8K | $422.6K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.